Serum Institute of India applies to DCGI to manufacture Sputnik V COVID vaccine, seeks indemnity

The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Sputnik V COVID-19 vaccine developed by Russia in the country, sources said on Thursday.

from Zee News :India National https://ift.tt/3wSP9M5

Post a Comment

0 Comments